A dose-response relationship study of SR141716 [rimonabant] in obese patients.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Rimonabant (Primary)
- Indications Obesity
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Sanofi
- 31 Aug 2018 Biomarkers information updated
- 14 Apr 2009 Actual patient number (527) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History